Showing 1 - 3 results of 3 for search 'Emilie Hein Zobel', query time: 0.03s Refine Results
  1. 1
    Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials

    Ceramides are decreased after liraglutide treatment in people with type 2 diabetes: a post hoc analysis of two randomized clinical trials by Asger Wretlind, Viktor Rotbain Curovic, Andressa de Zawadzki, Tommi Suvitaival, Jin Xu, Emilie Hein Zobel, Bernt Johan von Scholten, Rasmus Sejersten Ripa, Andreas Kjaer, Tine Willum Hansen, Tina Vilsbøll, Henrik Vestergaard, Peter Rossing, Cristina Legido-Quigley

    Published 2023-09-01
    Get full text
    Article
  2. 2
    The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes

    The effect of liraglutide and sitagliptin on oxidative stress in persons with type 2 diabetes by Suvanjaa Sivalingam, Emil List Larsen, Daniel H. van Raalte, Marcel H. A. Muskiet, Mark M. Smits, Lennart Tonneijck, Jaap A. Joles, Bernt Johan von Scholten, Emilie Hein Zobel, Frederik Persson, Trine Henriksen, Lars Jorge Diaz, Tine W. Hansen, Henrik Enghusen Poulsen, Peter Rossing

    Published 2021-05-01
    Get full text
    Article
  3. 3
    Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial

    Liraglutide Lowers Palmitoleate Levels in Type 2 Diabetes. A Post Hoc Analysis of the LIRAFLAME Randomized Placebo-Controlled Trial by Asger Wretlind, Asger Wretlind, Emilie Hein Zobel, Andressa de Zawadzki, Rasmus Sejersten Ripa, Rasmus Sejersten Ripa, Viktor Rotbain Curovic, Bernt Johan von Scholten, Bernt Johan von Scholten, Ismo Matias Mattila, Tine Willum Hansen, Andreas Kjær, Henrik Vestergaard, Henrik Vestergaard, Peter Rossing, Peter Rossing, Cristina Legido-Quigley, Cristina Legido-Quigley

    Published 2022-03-01
    Get full text
    Article

Search Tools: